About us

Baermed Group’s Profile

Baermed Group is a center of excellence for abdominal medicine and visceral surgery, biomedical research in tissue engineering, as well as the commercial use of biomedical mini-organs and cell matrix implants (including HEPADUA® Mini-Liver Implant).

Baermed Group is managed by Prof. Dr. med. Hans U. Baer. Our headquarters are located at Hirslanden Clinic, Zurich, and Tarumanagara Human Cell Technology Laboratory (THCT Lab) which is based in Tarumanagara University (UNTAR), Jakarta, Indonesia.

The Baermed Group is based on Baermed Bauchmedizin AG. It was founded on June 24, 2016 by Professor Dr. med. Hans U. Baer, and Dr. med. Christina Baer-Suryadinata, in Zurich. The Company is the legal successor of the simple partnership Baermed, which was founded in 1999 by Prof. Dr. med. Hans U. Baer to operate a practice for abdominal medicine and visceral surgery at the Hirslanden Clinic in Zurich.

The company is registered in the Commercial Register in Zurich under number TR 22250 of 24.06.2016 and SHAB 124 of 29.06.2016.

Organization

The Baermed Group is divided into three business units: Baermed Practice, Baermed Research and Baermed Solutions.

BAERMED GROUP
Baermed Bauchmedizin AG

Baermed Practice

Prof. Dr. med. Hans U. Baer runs his practice for abdominal medicine and visceral surgery at Hirslanden Clinic, Zurich and works with the following practice partners:

Practice Partner

• Medical team vivévis
• Medical Team Zurich Visceral Surgery (ZVC)
• Medical Team Surgical Center Zurich (CZZ)
• Swiss Surgery medical team

Baermed Research

Tarumanagara Human Cell Technology Laboratory (THCT Lab) as the Baermed Research Center is located at Tarumanagara University in Jakarta, Indonesia and specializes in the development of mini-organs and cell matrix implants. The research center was founded on the initiative of Prof. Dr. med. Hans U. Baer

Since 2010, Prof. Dr. med. Hans U. Baer has been conducting basic research in the field of tissue engineering and visceral cell matrix systems in collaboration with the Tarumanagara Human Cell Technologies Laboratory (THCT Lab), a research laboratory of the Faculty of Medicine of Tarumanagara University (UNTAR) in Jakarta, Indonesia. As international director, he leads the research work and coordinates international collaboration.

In addition to basic research, Prof. Dr. med. Hans U. Baer has also been conducting clinical research since 2010 in cooperation with the private hospital RS. Gading Pluit and the Liver Clinic Prof. Ali Sulaiman, both institutes based in Jakarta, Indonesia.

Basic research

The Tarumanagara Human Cell Technology Laboratory (THCT Lab) conducts research in the areas of cell biology, cell matrix, tissue engineering, and development of matrix supports for functional mini-organs.

After several years of basic research, Prof. Dr. med. Hans U. Baer and his team achieved a breakthrough in the “reproduction” of a functional mini-liver in 2018 with the “HEPADUA^® Mini-Liver Implant” project.

Clinical research

Since 2010, Prof. Dr. med. Hans U. Baer, has been conducting clinical research in collaboration with the Gading Pluit Private Hospital and the Liver Clinic in Jakarta, Indonesia. Currently, the interdisciplinary team is engaged in clinical trials (Phase I trial has been completed promisingly; Phase II trial started in March 2022) for the treatment of severe, chronic liver cirrhosis with the HEPADUA® Mini-Liver Implant.

Baermed Solutions

Baermed Solutions is engaged in the commercial use of biomedical mini-organs and cell matrix implants, as well as innovative treatments for patients with chronic liver disease and cirrhosis. Our focus is on the HEPADUA® Mini-Liver Implant.

As soon as clinical research with the current studies on the treatment of severe, chronic liver cirrhosis with liver cell matrix implants is successfully completed, the results will be made available to a broad group of patients.